biote Corp.
General ticker "BTMD" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $70.9M (TTM average)
biote Corp. does not follow the US Stock Market performance with the rate: -14.2%.
Estimated limits based on current volatility of 4.7%: low 1.07$, high 1.18$
Factors to consider:
- Total employees count: 223 (+2.8%) as of 2025
- US accounted for 97.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market acceptance, Practitioner contract loss, Labor/talent shortage/retention, Growth infrastructure strain, Regulatory and compliance
- Current price 43.0% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.91$, 3.87$]
- 2026-12-31 to 2027-12-31 estimated range: [2.19$, 4.26$]
Financial Metrics affecting the BTMD estimates:
- Positive: with PPE of 5.8 at the end of fiscal year the price was low
- Positive: Operating cash flow per share per price, % of 41.98 > 24.19
- Positive: 15.80 < Operating profit margin, % of 18.50
- Positive: Return on assets ratio (scaled to [-100,100]) of 22.70 > 10.70
- Positive: -11.23 < Investing cash flow per share per price, % of -8.19
- Positive: -4.55 < Industry operating profit margin (median), % of -0.34
- Positive: 3.66 < Industry operating cash flow per share per price (median), % of 4.90
Short-term BTMD quotes
Long-term BTMD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $185.36MM | $197.19MM | $192.22MM |
| Operating Expenses | $156.70MM | $165.58MM | $156.67MM |
| Operating Income | $28.66MM | $31.61MM | $35.55MM |
| Non-Operating Income | $-28.78MM | $-30.59MM | $2.03MM |
| Interest Expense | $6.36MM | $11.00MM | $10.96MM |
| Income(Loss) | $-0.12MM | $1.02MM | $37.58MM |
| Taxes | $2.68MM | $0.97MM | $5.99MM |
| Net Income(Loss)* | $3.32MM | $3.16MM | $27.05MM |
| Stockholders Equity | $-29.40MM | $-105.93MM | $-58.54MM |
| Assets | $155.29MM | $122.37MM | $107.61MM |
| Operating Cash Flow | $26.88MM | $45.24MM | $35.19MM |
| Capital expenditure | $2.71MM | $6.43MM | $5.01MM |
| Investing Cash Flow | $-2.71MM | $-18.80MM | $-6.86MM |
| Financing Cash Flow | $-14.38MM | $-76.08MM | $-43.55MM |
| Earnings Per Share** | $0.13 | $0.09 | $0.86 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.